Contact this trialFirst, we need to learn more about you.
Immunomodulator
Cyclophosphamide + Abatacept + Tacrolimus for Graft-versus-Host Disease
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is for adult patients with blood cancer who are undergoing a stem cell transplant from a donor who is a first- or second-degree relative. The patients will receive a reduced-intensity or myeloablative conditioning regimen, followed by peripheral blood hematopoietic stem cells. They will also receive cyclophosphamide, abatacept, and short-duration tacrolimus for GvHD prophylaxis.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.